Top Medical News
Jairia Dela Cruz, Yesterday
The selective serotonin reuptake inhibitor escitalopram holds promise in the prevention of Alzheimer’s disease, reducing amyloid-β-42 levels in cerebrospinal fluid and brain tissue in older adults with normal cognitive function, according to recent evidence.
26 Nov 2020
Patients with acute ischaemic stroke undergoing endovascular treatment are at heightened risk of poor functional outcome and symptomatic intracranial haemorrhage (sICH) in the presence of hyperglycaemia at admission, a study has found.
24 Nov 2020
Survivors of stroke with premorbid depression and diabetes mellitus may fare badly, being at increased risk of loss of independence and dementia, according to a study.
Roshini Claire Anthony, 23 Nov 2020

Subjective cognitive decline (SCD) or anxiety symptoms in older individuals are independently associated with an increased risk of mild cognitive impairment (MCI) or dementia, a recent study has shown.

Jairia Dela Cruz, 23 Nov 2020
Crushing prasugrel tablets and administering it as a powder to patients with ST-segment elevation myocardial infarction (STEMI) prior to percutaneous coronary intervention (PCI) enhances the potency of platelet inhibition but fails to improve early coronary reperfusion, as shown in the results of the COMPARE CRUSH trial.
21 Nov 2020
Chronic pain patients show high degrees of interest in nonpharmacological, behavioural interventions to their condition, a recent study has found. This interest is even greater among patients whose doctors recommended these treatments.
21 Nov 2020
Cupping seems to help ease short-term pain intensity and disability, reports a recent meta-analysis, although further studies are needed due to high clinical heterogeneity and risks of bias in the existing literature.
Special Reports
04 May 2018
Multiple sclerosis (MS) is one of the most common neurological disorders – affecting over 2.3 million people globally – and it is the leading cause of nontraumatic disability in young adults. However,the availability of supportive resources and services for people with MS is scarce in many regions of the world. In Malaysia, the prevalence of MS is estimated at 2-3/100,000; the current Malaysian clinical practice guidelines on the management of MS recommend disease modifying agents, such as interferon-β and teriflunomide, as first-line therapeutic agents. In this article, Dr Singer - in partnership with Sanofi and the Malaysian Society of Neurosciences - shares his insights into managing MS dynamically, highlighting the importance of early intervention in improving patient outcomes.
Conference Reports
Elvira Manzano, 28 Aug 2020

Post-infection mortality is higher in older patients with dementia than those without in an analysis of Danish national registry data presented at AAIC 2020.

Elvira Manzano, 28 Aug 2020
Having sleep apnoea or sleeping more than 9 hours every night doubles the risk of developing Alzheimer’s disease (AD) in middle-aged individuals within 6 years in a new study.
Roshini Claire Anthony, 21 Aug 2020

In patients diagnosed with chronic migraine and medication-overuse headache (MOH), treatment with eptinezumab led to improved patient-reported outcomes, fewer migraine days, and a reduction in acute medication use, according to subgroup analyses of the PROMISE-2* trial presented at AHS 2020.

Roshini Claire Anthony, 20 Aug 2020

Calcium channel blockers (CCBs) and angiotensin II receptor blockers (ARBs) may be associated with a reduced risk of dementia, according to a systematic review and network meta-analysis conducted by researchers from the Netherlands.

Audrey Abella, 20 Aug 2020
Use of the antipsychotic drug pimavanserin led to a substantial reduction in psychosis symptoms in individuals with dementia regardless of severity or subtype, according to the results of the HARMONY trial presented at AAIC 2020.
Pearl Toh, 19 Aug 2020
A new blood test for plasma P-tau217* accurately differentiates Alzheimer's disease (AD) from other neurodegenerative diseases — showing promise as a blood-based biomarker for early detection of AD, according to a study presented at the AAIC 2020 Meeting.
Roshini Claire Anthony, 17 Aug 2020

Regular influenza and pneumococcal vaccinations may help stave off the development of Alzheimer’s disease (AD), according to two studies presented at AAIC 2020.